scholarly journals Sequence of the cDNA of a human dihydrodiol dehydrogenase isoform (AKR1C2) and tissue distribution of its mRNA

1998 ◽  
Vol 334 (2) ◽  
pp. 399-405 ◽  
Author(s):  
Hiroaki SHIRAISHI ◽  
Syuhei ISHIKURA ◽  
Kazuya MATSUURA ◽  
Yoshihiro DEYASHIKI ◽  
Mitsuo NINOMIYA ◽  
...  
Keyword(s):  
Human Liver ◽  
Human Colon ◽  
Hydroxysteroid Dehydrogenase ◽  
The Other ◽  
Specific Primers ◽  
Tissue Samples ◽  
Mrna Species ◽  
Ht29 Cells ◽  
Human Colon Carcinoma ◽  
Dihydrodiol Dehydrogenase

Human liver contains three isoforms (DD1, DD2 and DD4) of dihydrodiol dehydrogenase with 20α- or 3α-hydroxysteroid dehydrogenase activity; the dehydrogenases belong to the aldo–oxo reductase (AKR) superfamily. cDNA species encoding DD1 and DD4 have been identified. However, four cDNA species with more than 99% sequence identity have been cloned and are compatible with a partial amino acid sequence of DD2. In this study we have isolated a cDNA clone encoding DD2, which was confirmed by comparison of the properties of the recombinant and hepatic enzymes. This cDNA showed differences of one, two, four and five nucleotides from the previously reported four cDNA species for a dehydrogenase of human colon carcinoma HT29 cells, human prostatic 3α-hydroxysteroid dehydrogenase, a human liver 3α-hydroxysteroid dehydrogenase-like protein and chlordecone reductase-like protein respectively. Expression of mRNA species for the five similar cDNA species in 20 liver samples and 10 other different tissue samples was examined by reverse transcriptase-mediated PCR with specific primers followed by diagnostic restriction with endonucleases. All the tissues expressed only one mRNA species corresponding to the newly identified cDNA for DD2: mRNA transcripts corresponding to the other cDNA species were not detected. We suggest that the new cDNA is derived from the principal gene for DD2, which has been named AKR1C2 by a new nomenclature for the AKR superfamily. It is possible that some of the other cDNA species previously reported are rare allelic variants of this gene.

scholarly journals Identification of amino acid residues responsible for differences in substrate specificity and inhibitor sensitivity between two human liver dihydrodiol dehydrogenase isoenzymes by site-directed mutagenesis

1997 ◽  
Vol 323 (1) ◽  
pp. 61-64 ◽  
Author(s):  
Kazuya MATSUURA ◽  
Yoshihiro DEYASHIKI ◽  
Kumiko SATO ◽  
Naoko ISHIDA ◽  
Gunpei MIWA ◽  
...  
Keyword(s):  
Amino Acid ◽  
Human Liver ◽  
Hydroxysteroid Dehydrogenase ◽  
The Other ◽  
Site Directed Mutagenesis ◽  
Directed Mutagenesis ◽  
Amino Acid Residues ◽  
Dihydrodiol Dehydrogenase ◽  
Inactive Protein

Human liver dihydrodiol dehydrogenase isoenzymes (DD1 and DD2), in which only seven amino acid residues are substituted, differ remarkably in specificity for steroidal substrates and inhibitor sensitivity: DD1 shows 20α-hydroxysteroid dehydrogenase activity and sensitivity to 1,10-phenanthroline, whereas DD2 oxidizes 3α-hydroxysteroids and is highly inhibited by bile acids. In the present study we performed site-directed mutagenesis of the seven residues (Thr-38, Arg-47, Leu-54, Cys-87, Val-151, Arg-170 and Gln-172) of DD1 to the corresponding residues (Val, His, Val, Ser, Met, His and Leu respectively) of DD2. Of the seven mutations, only the replacement of Leu-54 with Val produced an enzyme that had almost the same properties as DD2. No significant changes were observed in the other mutant enzymes. An additional site-directed mutagenesis of Tyr-55 of DD1 to Phe yielded an inactive protein, suggesting the catalytically important role of this residue. Thus a residue at a position before the catalytic Tyr residue might play a key role in determining the orientation of the substrates and inhibitors.

scholarly journals Kinetic alteration of a human dihydrodiol/3α-hydroxysteroid dehydrogenase isoenzyme, AKR1C4, by replacement of histidine-216 with tyrosine or phenylalanine

2000 ◽  
Vol 352 (3) ◽  
pp. 685-691 ◽  
Author(s):  
Tatuya OHTA ◽  
Syuhei ISHIKURA ◽  
Syunichi SHINTANI ◽  
Noriyuki USAMI ◽  
Akira HARA
Keyword(s):  
Hydroxysteroid Dehydrogenase ◽  
Clofibric Acid ◽  
The Other ◽  
Flufenamic Acid ◽  
Histidine Residue ◽  
Tyrosine Residue ◽  
Wild Type ◽  
Wild Type Enzyme ◽  
Competitive Inhibitors ◽  
Dihydrodiol Dehydrogenase

Human dihydrodiol dehydrogenase with 3α-hydroxysteroid dehydrogenase activity exists in four forms (AKR1C1Ő1C4) that belong to the aldoŐketo reductase (AKR) family. Recent crystallographic studies on the other proteins in this family have indicated a role for a tyrosine residue (corresponding to position 216 in these isoenzymes) in stacking the nicotinamide ring of the coenzyme. This tyrosine residue is conserved in most AKR family members including AKR1C1Ő1C3, but is replaced with histidine in AKR1C4 and phenylalanine in some AKR members. In the present study we prepared mutant enzymes of AKR1C4 in which His-216 was replaced with tyrosine or phenylalanine. The two mutations decreased 3-fold the Km for NADP+ and differently influenced the Km and kcat for substrates depending on their structures. The kinetic constants for bile acids with a 12α-hydroxy group were decreased 1.5Ő7-fold and those for the other substrates were increased 1.3Ő9-fold. The mutation also yielded different changes in sensitivity to competitive inhibitors such as hexoestrol analogues, 17β-oestradiol, phenolphthalein and flufenamic acid and 3,5,3´,5´-tetraiodothyropropionic acid analogues. Furthermore, the mutation decreased the stimulatory effects of the enzyme activity by sulphobromophthalein, clofibric acid and thyroxine, which increased the Km for the coenzyme and substrate of the mutant enzymes more highly than those of the wild-type enzyme. These results indicate the importance of this histidine residue in creating the cavity of the substrate-binding site of AKR1C4 through the orientation of the nicotinamide ring of the coenzyme, as well as its involvement in the conformational change by binding non-essential activators.

Up-regulation of Hsp27 Plays a Role in the Resistance of Human Colon Carcinoma HT29 Cells to Photooxidative Stress¶

2007 ◽  
Vol 76 (1) ◽  
pp. 98-104 ◽  
Author(s):  
Hong P. Wang ◽  
John G. Hanlon ◽  
Andrew J. Rainbow ◽  
Myrna Espiritu ◽  
Gurmit Singh
Keyword(s):  
Colon Carcinoma ◽  
Human Colon ◽  
Photooxidative Stress ◽  
Ht29 Cells ◽  
Human Colon Carcinoma

scholarly journals Characterization of a family of structurally related glycoproteins expressing β1-6-branched asparagine-linked oligosaccharides in human colon carcinoma cells

1992 ◽  
Vol 283 (1) ◽  
pp. 193-201 ◽  
Author(s):  
S Laferté ◽  
L C Loh
Keyword(s):  
Colon Cancer ◽  
Colon Carcinoma ◽  
Cell Lines ◽  
Culture Medium ◽  
Carcinoma Cell ◽  
Human Colon ◽  
Human Colon Carcinoma Cell ◽  
Ht29 Cells ◽  
Human Colon Carcinoma

Previous studies have established that metastatic tumour cells express high levels of beta 1-6-branched Asn-linked oligosaccharides which can be detected with the lectin leucoagglutinin (L-PHA) [Dennis, Laferté, Waghorne, Breitman & Kerbel (1987) Science 236, 582-585]. In order to identify L-PHA-binding glycoproteins which may play a role specifically in colon cancer, we have prepared monoclonal antibodies (MAbs) to the moderately well-differentiated human colon carcinoma cell line HT29. In this paper we present the initial characterization of a family of structurally related L-PHA-binding glycoproteins detected by MAb 1H9 which are differentially expressed and processed by HT29 cells and by two other human colon carcinoma cell lines, SW480 and SW620. In contrast to HT29, the SW480 and SW620 cell lines were established from a poorly differentiated grade III/IV primary tumour and one of its lymph node metastases respectively. MAb 1H9 detects in HT29 cells a conformational determinant present on three L-PHA-binding glycoproteins of 100, 70 and 25kDa, as well as a 74 kDa glycoprotein with high-mannose-type Asn-linked oligosaccharides. Pulse-chase experiments and peptide mapping analyses revealed that the 74 kDa and 100 kDa species are related by carbohydrate processing and are probably derived from a common 76 kDa precursor. On the other hand, the 70 kDa glycoprotein is synthesized from an endoglycosidase H-sensitive precursor of 56 kDa which is structurally related to, but distinct from, the aforementioned 76 kDa precursor. In addition, the 100 kDa species is secreted into the culture medium, whereas the 70 kDa glycoprotein is retained intracellularly. SW480 and SW620 cells showed qualitative and quantitative differences from HT29 cells, including increased secretion of a smaller L-PHA-binding glycoprotein of 92 kDa into the culture medium, as well as apparent differences in glycosylation of the intracellular 66 kDa glycoprotein. These results suggested that the expression, glycosylation and subcellular localization of this family of L-PHA-binding glycoproteins may correlate with the differentiation status of colon cancer cells and/or reflect biochemical changes. characteristic of more progressive metastatic tumours.

Sign in / Sign up

Export Citation Format

Share Document